Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism

Neurotoxicity Research

Volumn 13, Issue 3-4, 2008, Pages 151-161

  Rasmussen, Bruce A ^a,c   Perry, David C ^a   O'Neil, Jahn ^b   Manaye, Kebreten F ^b   Tizabi, Yousef ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Acoustic startle response; Dizocilpine, MK 801; Nicotine; Nicotinic receptors; NMDA antagonist; Prepulse inhibition (PPI); Schizophrenia model

Indexed keywords

DIZOCILPINE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR; PILOCARPINE; SODIUM CHLORIDE; BUNGAROTOXIN; DIZOCILPINE MALEATE; EPIBATIDINE; FUSED HETEROCYCLIC RINGS; ISOTOPE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN; NICOTINIC AGENT; PYRIDINE DERIVATIVE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY RESPONSE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; MORNING DOSAGE; NEUROTOXICITY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SPRAGUE DAWLEY RAT; STIMULUS RESPONSE; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; AUDITORY STIMULATION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; INHIBITION (PSYCHOLOGY); METABOLISM; METHODOLOGY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN BINDING; STARTLE REFLEX;

ANIMALIA; RATTUS;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BUNGAROTOXINS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAIT DISORDERS, NEUROLOGIC; INHIBITION (PSYCHOLOGY); ISOTOPES; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEUROTOXINS; NICOTINE; NICOTINIC AGONISTS; PILOCARPINE; PROTEIN BINDING; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SCOPOLAMINE; STARTLE REACTION;

EID: 51849165691     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033499     Document Type: Article

References (74)

1. Acri JB, DE Morse, EJ Popke and NE Grunberg (1994) Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology 114, 369-374.
2. Acri JB, KJ Brown, MI Saah and NE Grunberg (1995) Strain and age differences in acoustic startle responses and effects of nicotine in rats. Pharmacol. Biochem. Behav. 50, 191-198.
3. Adler LE, LJ Hoffer, J Griffith, MC Waldo and R Freedman (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 32, 607-616.
4. Adler LE, LD Hoffer, A Wiser and R Freedman (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150, 1856-1861.
5. Aizenman E, LH Tang and IJ Reynolds (1991) Effects of nicotinic agonists on the NMDA receptor. Brain Res. 551, 355-357.
6. Alkondon M, EF Pereira and EX Albuquerque (2003) NMDA and AMPA receptors contribute to the nicotinic cholinergic excitation of CA1 interneurons in the rat hippocampus. J. Neurophysiol. 90, 1613-1625.
7. Andreasen T, KK Andersen, EØ Nielson, L Mathiasen and NR Mirza (2006) Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone. Behav. Brain Res. 167, 118-127.
8. 7 nicotinic acetylcholine receptors more potently than N -methyl-D-aspartate receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 312, 1195-1205.
9. Aramakis VB and R Metherate (1998) Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J. Neurosci. 18, 8485-8495.
10. Becker A, B Peters, H Schroeder, T Mann, G Huether and G Grecksch (2003) Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 687-700.
11. Braff DL, MA Geyer and NR Swerdlow (2001) Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234-258.
12. Breese CR, R Freedman and SS Leonard (1995) Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674, 82-90.
13. Breese CR, MJ Lee, CE Adams, B Sullivan, J Logel, KM Gillen, MJ Marks, AC Collins and S Leonard (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23, 351-364.
14. 2 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53, 555-563.
15. Campbell VC, RE Taylor and Y Tizabi (2006) Antinociceptive effects of alcohol and nicotine: Involvement of the opioid system. Brain Res. 1097, 71-77.
16. Campbell VC, RE Taylor and Y Tizabi (2007) Effects of selective opioid receptor antagonists on alcohol and nicotineinduced antinociception. Alc. Clin. Exp. Res. 31, 1435-1440.
17. Corso TD, MA Sesma, TI Tenkova, TC Der, DF Wozniak, NB Farber and JW Olney (1997) Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 752, 1-14.
18. Coyle JT (2006) Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms. Neurotox. Res. 10, 221-233.
19. Dalack GW, DJ Healy and JH Meador-Woodruff (1998) Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. Am. J. Psychiatr. 155, 1490-1501.
20. de Leon J and FJ Diaz (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76, 135-157.
21. 7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology 29, 1522-1526.
22. 2 subunits of high affinity nicotinic receptor: Analysis in schizophrenia. Exp. Brain Res. 174, 292-296.
23. Deutsch SI, K Long, RB Rosse, AS Bellack, Y Tizabi, R Weizman, J Eller and J Mastropaolo (2006) Animal models of psychosis, In: Transgenic and Knockout Models of Neuropsychiatric Disorders (Fisch GS and J Flint, Eds.) (Humana Press:TOtowa, NJ), pp 193-220.
24. Domino EF, D Mirzoyan and H Tsukada (2004) N-methyl-Daspartate antagonists as drug models of schizophrenia: A surprising link to tobacco smoking. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 801-811.
25. Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann. NY Acad. Sci. 1003, 119-130.
26. Farber NB, DF Wozniak, MT Price, J Labruyere, J Huss, H St Peter and JW Olney (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Biol. Psychiatry 38, 788-796.
27. 7 -nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 20, 299-306.
28. Freedman R, S Leonard, M Waldo, J Gault, A Olincy and LE Adler (2006) Characterization of allelic variants at chromosome 15q14 in schizophrenia. Genes Brain Behav. 5 Suppl. 1, 14-22.
29. George TP, A Termine, KA Sacco, TM Allen, E Reutenauer, JC Vessicchio and EJ Duncan (2006) A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: Involvement of nicotinic receptor mechanisms. Schizophr. Res. 87, 307-315.
30. Geyer MA, K Krebs-Thomson, DL Braff and NR Swerdlow (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology 156, 117-154.
31. Goff DC, DC Henderson and E Amico (1992) Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am. J. Psychiatry 149, 1189-1194.
32. Gotti C and F Clementi (2004) Neuronal nicotinic receptors: From structure to pathology. Prog. Neurobiol. 74, 363-396.
33. 7 subunit in the frontal cortex from schizophrenic brain. NeuroReport 10, 1779-1782.
34. Harrison PJ, AJ Law and SL Eastwood (2003) Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann. NY Acad. Sci. 1003, 94-101.
35. 7 nicotinic receptors. Eur. J. Pharmacol. 553, 191-195.
36. Javitt DC and SR Zukin (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
37. Jentsch JD and RH Roth (1999) The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
38. Jones CK, EL Eberle, DB Shaw, DL McKinzie and HE Shannon (2005) Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats. J. Pharmacol. Exp. Ther. 312, 1055-1063.
39. Kumari V and P Postma (2005) Nicotine use in schizophrenia: The self medication hypotheses. Neurosci. Biobehav. Rev. 29, 1021-1034.
40. Laruelle M, LS Kegeles and A Abi-Dargham (2003) Glutamate, dopamine, and schizophrenia: From pathophysiology to treatment. Ann. NY Acad. Sci. 1003, 138-158.
41. Leonard S, J Gault, C Adams, CR Breese, Y Rollins, LE Adler, A Olincy and R Freedman (1998) Nicotinic receptors, smoking and schizophrenia. Restor. Neurol. Neurosci. 12, 195-201.
42. Levin ED, A Petro and DP Caldwell (2005a) Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 581-586.
43. Levin ED, Y Tizabi, AH Rezvani, D Caldwell, A Petro and B Getachew (2005b) Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. Brain Res. 1041, 132-142.
44. 7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22, 5001-5015.
45. Lukas RJ and M Bencherif (1992) Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34, 25-131.
46. Mackeprang T, KT Kristiansen and BY Glenthoj (2002) Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol. Psychiatry 52, 863-873.
47. 7 nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem. 80, 1071-1078.
48. Marks MJ, JB Burch and AC Collins (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817-825.
49. Martinez ZA, GD Ellison, MA Geyer and NR Swerdlow (1999) Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology 21, 28-39.
50. Martinez ZA, A Platten, E Pollack, J Shoemaker, H Ro, L Pitcher, MA Geyer and NR Swerdlow (2002) "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats. Psychopharmacology 161, 38-46.
51. 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br. J. Pharmacol. 140, 1313-1319.
52. Meador-Woodruff JH, SM Clinton, M Beneyto and RE McCullumsmith (2003) Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann. NY Acad. Sci. 1003, 75-93.
53. Nespor AA, JN O'Neil, KF Manaye and Y Tizabi (2002) Chronic nicotine administration attenuates quinpiroleinduced disruption in prepulse inhibition in rats. Soc Neuorsci. Abstr.
54. Nguyen HN, BA Rasmussen and DC Perry (2003) Subtypeselective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J. Pharmacol. Exp. Ther. 307, 1090-1097.
55. Pauly JR, MJ Marks, SD Gross and AC Collins (1991) An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J. Pharmacol. Exp. Ther. 258, 1127-1136.
56. Picciotto MR (2003) Nicotine as a modulator of behavior: Beyond the inverted U. Trends Pharmacol. Sci. 24, 493-499.
57. Rasmussen BA, J O'Neil, KF Manaye, DC Perry and Y Tizabi (2007) Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats. Psychopharmacology 190, 43-49.
58. 125I] α-bungarotoxin binding in rat brain after chronic nicotine exposure. Neurosci. Lett. 404, 9-14.
59. 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice. Psychopharmacology 159, 248-257.
60. Schwartz RD and KJ Kellar (1983) Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo. Science 220, 214-216.
61. Shoaib M, CW Schindler, SR Goldberg and JR Pauly (1997) Behavioural and biochemical adaptations to nicotine in rats: Influence of MK801, an NMDA receptor antagonist. Psychopharmacology 134, 121-130.
62. Siegel C, M Waldo, G Mizner, LE Adler and R Freedman (1984) Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry 41, 607-612.
63. Stanhope KJ, NR Mirza, MJ Bickerdike, JL Bright, NR Harrington, MB Hesselink, GA Kennett, S Lightowler, MJ Sheardown, R Syed, RL Upton, G Wadsworth, SM Weiss and A Wyatt (2001) The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J. Pharmacol. Exp. Ther. 299, 782-792.
64. Swerdlow NR, MA Geyer and D Braff (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology 156, 194-215.
65. Tamminga CA, AC Lahti, DR Medoff, XM Gao and HH Holcomb (2003) Evaluating glutamatergic transmission in schizophrenia. Ann. NY Acad. Sci. 1003, 113-118.
66. Tizabi Y (2007) Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia. Neurotox. Res. 12, 233-246.
67. Tizabi Y, J Mastropaolo, CH Park, L Riggs, D Powell, RB Rosse and SI Deutsch (1998) Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: Psychiatric implications. Psychopharmacology 140, 202-205.
68. Tizabi Y, DH Overstreet, AH Rezvani, VA Louis, E Clark Jr, D Janowsky and MA Kling (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142, 193-199.
69. Tizabi Y, N Bromley, AA Nespor and KF Manaye (2002) Antidepressant effects of nicotine in WKY rats, a putative animal model of depression. Soc. Neurosci. Abstr.
70. Tizabi Y, R Madani, SR Hauser and F Manaye (2004) Effects of chronic nicotine in WKY rats, a putative animal model of depression. Soc. Neurosci. Abstr.
71. Tizabi Y, L Bai, RL Copeland Jr and RE Taylor (2007) Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell. Alc..Alc. 42(5), 413-416. Epub 2007 Aug 8.
72. 1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: A PET study in conscious monkeys. Neuropsychopharmacology 30, 2144-2153.
73. Wozniak DF, K Dikranian, MJ Ishimaru, A Nardi, TD Corso, T Tenkova, JW Olney and AS Fix (1998) Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: Potential relevance to Alzheimer's disease. Neurobiol. Dis. 5, 305-322.
74. Yamakura T, LE Chavez-Noriega and RA Harris (2000) Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine. Anesthesiology 92, 1144-1153.